Abbott Laboratories (ABT) (JOBS) to Acquire Novel Investigational Biologic from PanGenetics B.V.'s to Treat Chronic Pain for $190 Million
11/12/2009 7:17:44 AM
More...
|
PanGenetics B.V. Receives Approval for Clinical Evaluation of Anti-NGF Antibody in Patients with Chronic Pain
6/8/2009 10:31:42 AM
More...
|
PanGenetics B.V. To Initiate Clinical Study Of CD40 Antagonist Antibody In Psoriatic Arthritis
10/6/2008 11:14:13 AM
More...
|
PanGenetics B.V. Raises 23 Million Euro in Series C Financing to Fund Clinical Advancement of Its Therapeutic Antibody Programs
3/5/2008 7:11:50 AM
More...
|
PanGenetics B.V. Licenses Therapeutic Antibody For Treatment Of Pain From Lay Line Genomics S.p.A.
12/7/2006 11:31:04 AM
More...
|